Scarica l'app Stockscreener
63.00
0.63%
-0.40
Dopo l'orario di chiusura:
63.01
0.010
+0.02%
Monopar Therapeutics Inc Borsa (MNPR) Ultime notizie
Monopar Therapeutics initiated with an Overweight at Morgan Stanley - TipRanks
Morgan Stanley Initiates Coverage on Monopar Therapeutics (MNPR) with Overweight Rating | MNPR Stock News - GuruFocus
Morgan Stanley initiates Monopar Therapeutics stock with Overweight rating By Investing.com - Investing.com Canada
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Average Rating of “Buy” from Brokerages - Defense World
How risky is Monopar Therapeutics Inc. stock nowWeekly Investment Recap & Free Community Consensus Stock Picks - ulpravda.ru
Will Monopar Therapeutics Inc. stock return to pre crisis levelsJuly 2025 News Drivers & Fast Moving Stock Watchlists - ulpravda.ru
Can Monopar Therapeutics Inc. stock hit record highs again2025 Macro Impact & Weekly Return Optimization Alerts - ulpravda.ru
Published on: 2026-01-09 02:04:15 - ulpravda.ru
Will Monopar Therapeutics Inc. stock keep outperforming rivalsEntry Point & Low Risk Investment Opportunities - ulpravda.ru
Published on: 2026-01-08 22:24:28 - ulpravda.ru
symbol__ Stock Quote Price and Forecast - CNN
Trading the Move, Not the Narrative: (MNPR) Edition - Stock Traders Daily
EPS Watch: What dividend safety score for Monopar Therapeutics Inc. stock2025 Momentum Check & Verified Swing Trading Watchlists - moha.gov.vn
Monopar Therapeutics announces pricing of $135M offering - MSN
Aug Gainers: Why Monopar Therapeutics Inc stock appeals to analystsProfit Target & Fast Momentum Stock Entry Tips - moha.gov.vn
Hedge Fund Moves: Is Monopar Therapeutics Inc stock a buy for dividend growthSwing Trade & Technical Entry and Exit Alerts - moha.gov.vn
Top Executive Makes Bold Insider Move at Monopar Therapeutics - TipRanks
Insider Buying: Quan Vu Acquires Shares of Monopar Therapeutics Inc (MNPR) - GuruFocus
Monopar Therapeutics (NASDAQ:MNPR) CFO Purchases 1,500 Shares - MarketBeat
Monopar therapeutics CFO Vu Quan Anh buys $104925 in shares By Investing.com - Investing.com Canada
Monopar Therapeutics (NASDAQ:MNPR) Sharpens Focus on Molecular Targeting - Kalkine Media
Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's What You Should Know - MSN
Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Update - MarketBeat
Responsive Playbooks and the MNPR Inflection - Stock Traders Daily
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025 - Zacks Investment Research
Independent Director Arthur Klausner Sold A Bunch Of Shares In Monopar Therapeutics - simplywall.st
What dividend safety score for Monopar Therapeutics Inc. stockStop Loss & AI Powered Buy and Sell Recommendations - Улправда
Major Insider Move Shakes Up Investor Watch on Monopar Therapeutics - TipRanks
Is Monopar Therapeutics Inc. stock a safe haven assetJuly 2025 Summary & Accurate Intraday Trading Signals - Улправда
Insider Sell: Arthur Klausner Sells Shares of Monopar Therapeuti - GuruFocus
Dir Klausner Files To Sell 5,121 Of Monopar Therapeutics Inc [MNPR] - TradingView — Track All Markets
Monopar Therapeutics Director Sells Over 5,000 Shares - TradingView — Track All Markets
Monopar Therapeutics Insider Sold Shares Worth $343,889, According to a Recent SEC Filing - marketscreener.com
Dir Klausner Sells 5,121 ($343.9K) Of Monopar Therapeutics Inc [MNPR] - TradingView — Track All Markets
Monopar Therapeutics (FRA:1IY0) EV-to-OCF : -25.58 (As of Dec. 19, 2025) - GuruFocus
Will Monopar Therapeutics Inc. stock gain from strong economyWeekly Stock Report & Weekly High Conviction Ideas - DonanımHaber
Why retail investors favor Monopar Therapeutics Inc. stock2025 Momentum Check & Community Shared Stock Ideas - DonanımHaber
Why Monopar Therapeutics Inc. stock appeals to analystsJuly 2025 PreEarnings & High Return Stock Watch Alerts - DonanımHaber
Is Monopar Therapeutics Inc. (1IY0) stock a good hedge against inflation2025 Retail Activity & Technical Buy Zone Confirmation - DonanımHaber
How cyclical is Monopar Therapeutics Inc. (1IY0) stock compared to rivalsGold Moves & High Accuracy Swing Trade Signals - Улправда
Treasury Yields: How cyclical is Monopar Therapeutics Inc. (1IY0) stock compared to rivalsInsider Buying & Community Verified Trade Signals - Улправда
Monopar Therapeutics (MNPR) director details 43,499-share distribution in Form 4 - Stock Titan
Monopar Therapeutics (MNPR) director receives 7,710 common shares via distribution - Stock Titan
(MNPR) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Monopar Therapeutics (NASDAQ:MNPR) Rating Increased to Hold at Wall Street Zen - Defense World
Monopar Therapeutics Inc. (NASDAQ:MNPR) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Monopar Therapeutics Inc. (NASDAQ:MNPR) Given Average Recommendation of “Buy” by Brokerages - Defense World
Monopar Therapeutics (NASDAQ:MNPR) Upgraded at Wall Street Zen - MarketBeat
Analysts’ Top Healthcare Picks: Aardvark Therapeutics, Inc. (AARD), Eli Lilly & Co (LLY) - The Globe and Mail
Aug Catalysts: How interest rate cuts could boost Monopar Therapeutics Inc stockGap Up & High Accuracy Trade Alerts - moha.gov.vn
Monopar Therapeutics (NASDAQ:MNPR) Shares Up 6.3%Should You Buy? - MarketBeat
Monopar Therapeutics (NASDAQ:MNPR) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Will Monopar Therapeutics Inc. stock benefit from commodity prices2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
Will Monopar Therapeutics Inc. (1IY0) stock rise with strong economyShare Buyback & Free Weekly Watchlist of Top Performers - Newser
How Monopar Therapeutics Inc. (1IY0) stock behaves in tightening cyclesJuly 2025 Setups & Consistent Growth Equity Picks - Newser
Is Monopar Therapeutics Inc. (1IY0) stock a safe buy pre earningsJuly 2025 Gainers & Verified Technical Signals - Newser
How (MNPR) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Monopar Therapeutics (NASDAQ:MNPR) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
How Monopar Therapeutics Inc. (1IY0) stock correlates with oil markets2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):